期刊文献+

血红蛋白变异率对规律血液透析患者长期预后的影响及相关因素分析 被引量:2

The influence of hemoglobin variability rate on the prognosis of patients treated with routine dialysis and its relative factors
下载PDF
导出
摘要 目的研究血红蛋白变异率对血液透析患者预后的影响,并分析血红蛋白变异率的影响因素。方法选取2010年1月至2015年1月期间368例规律血液透析患者作为研究对象,将患者根据预后分为死亡组(49例)、并发症组(172例)及非并发症组(147例)。比较各组患者的临床资料,分析患者预后与血红蛋白变异率的相关性,并分析血红蛋白变异率的影响因素。结果不同预后患者的血红蛋白变异率具有显著的相关性(P<0.05)。患者血红蛋白变异率与年龄、血浆总蛋白、透析前血红蛋白水平、促红细胞生成素及铁剂应用具有显著的相关性(P<0.05)。结论规律性血液透析患者血红蛋白变异率与患者长期预后具有相关性。 Objective To study the influence of hemoglobin variability rate on the prognosis of patients treated with routine dialysis, as well to analyze its relative factors. Methods From January 2010 to January 2015, 368 patients were chosen as study objects, and all patients were divided into 3 groups :49 in death group, 172 in complication group and 147 in non -complication group, the clinical data of different groups were compared. The correlation of hemoglobin variability rate with prognosis were analyzed and the relative factors of hemoglobin variability rate were analyzed. Results The prognosis of patients demonstrated significant relativity with hemoglobin variability rate ( P 〈 0.05 ). The hemoglobin variability rate had significant relativity with age, total protein, hemoglobin, and the use of Erythropoietin and chalybeate. Conclusion The hemoglobin variability rate of patients treated with routine dialysis has significant relativity with prognosis of patients.
出处 《临床和实验医学杂志》 2016年第22期2243-2246,共4页 Journal of Clinical and Experimental Medicine
关键词 血液透析 血红蛋白变异 预后 Dialysis Hemoglobin variability Prognosis
  • 相关文献

参考文献10

二级参考文献84

  • 1王笑云.慢性血管通路并发症防治[J].中国血液净化,2007,6(7):352-355. 被引量:12
  • 2王海燕,王梅.慢性肾脏病及透析的临床实践指南(附评述)[M].北京:人民卫生出版社,2003:1-301.
  • 3K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative[ J]. Am J Kidney Dis ,2002,39( Suppl 2 ) :S1 - S246.
  • 4The Diabetes Control and Complications Trail Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[ J]. N Engl J Med ,1993 ,329 :977 -986.
  • 5Klahr S, Levey AS, Greene T, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group [J]. N Engl J Med,1994,330:844 -877.
  • 6KDOQI. KDOQI Clinical Practice Guideline and ClinicalPractice Recommendations for anemia in chronic kidneydisease: 2007 update of hemoglobin target. Am J Kidney Dis,2007,50: 471-530.
  • 7Bems JS, Elzein H, Lynn RI, et al. Hemoglobin variability inepoetin - treated hemodialysis patients. Kidney Int, 2003, 64:1514-1521.
  • 8Szeto CC, Kwan BC, Chow KM, et al. Haemoglobin variabilityin Chinese pre - dialysis CKD patients not receivingerythropoietin. Nephrol Dial Transplant, 2011,26: 2919-2924.
  • 9Wish JB. Hemoglobin variability as a predictor of mortality:What's a practitioner to do? Am J Kidney Dis, 2011, 57: 190-193.
  • 10SINGH A K, SZCZECH L, TANG K L, et al. Correction ofanemia with epoetin alfa in chronic kidney disease. New EnglJ Med, 2006, 355: 2085-2098.

共引文献183

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部